The Impact of the COVID-19 Pandemic on the Quality of Care of Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept.

Reinhard AngermannAlexander FranchiKatharina FredeJulia RettenwanderTanja RettenwanderJulia NeyerMartin StattinMartina KralingerClaus Zehetner

Published in: Klinische Monatsblatter fur Augenheilkunde (2022)

We confirmed significantly worse VA outcomes in the group of nAMD patients treated during the COVID-19 pandemic. Impeded access to care could be attributed to the restrictions imposed owing to the COVID-19 pandemic.

Keyphrases

age related macular degeneration
quality improvement
healthcare
palliative care
pain management
affordable care act
type diabetes
adipose tissue
skeletal muscle
metabolic syndrome
chronic pain
weight loss
diabetic retinopathy